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Understanding how metals contribute to brain function is a major health priority. A new study combining 
pharmacology and genetics implicates the accumulation of copper in a brain arousal center as a 
regulator of zebrafish activity.  
The brain is a ravenous user of transition metals, especially copper, zinc, and iron. These metals serve as 
critical co-factors for enzymes that play fundamental roles in the regulation of DNA, cellular metabolism, 
redox regulation, neuronal firing, and synaptic plasticity.  Little wonder then that the disruption of metal 
homeostasis in the brain has been linked to myriad neurodegenerative diseases, including amyotrophic 
lateral sclerosis, Alzheimer’s, and Parkinson’s disease1. A better understanding of how metals impact 
normal brain function will therefore likely provide insights into disease, but methodological challenges 
of observing and manipulating metals in vivo have hindered progress. Xiao et al. leverage the optical 
translucency and facile genetics of the zebrafish to demonstrate how deficiency in one metal, copper, 
alters the behavioral output of an arousal-regulating neuronal circuit2. 
Copper is an essential trace element that strongly accumulates in the brain, where it participates in 
maintaining the redox balance of our most energetic organ. Copper is also an essential co-factor for 
many enzymatic reactions involved in critical brain functions3. One such enzyme is dopamine-beta 
hydroxylase (DBH), which serves in the final biosynthetic step in the production of the neurotransmitter 
norepinephrine (NE). NE is predominantly made by neurons in a small brainstem area called the locus 
coeruleus (LC), incidentally the site of the highest copper concentrations in the human brain4. NE-
expressing neurons in the LC send widespread processes throughout the brain and are a major positive 
regulator of arousal and wakefulness in vertebrates5. Although some patients with genetic disruption of 
copper metabolism (e.g. Wilson’s disease) report daytime sleepiness6, whether copper deficiency alters 
NE production in the LC to impact sleep-wake behavior had not been tested. 
To investigate a copper-LC-behavior connection, Xiao et al. turned to the larval zebrafish, an excellent 
system in which to forge these links because of the ability to image deep into the brain and to readily 
manipulate behavior with genetics and pharmacology. The authors first developed a novel molecular 
sensor of copper, Copper Fluor-4 (CF4), which, together with the copper insensitive dye, Control Copper 
Fluor-4 Sulfur 2 (Ctrl-CF4-S2), can penetrate into the live zebrafish brain and sensitively visualize copper 
levels with high selectivity over zinc and iron. Using these dyes together with direct measurements of 
total copper distribution in the brain by Laser Ablation Inductively Coupled Plasma Mass Spectrometry 
(LA-ICP-MS), they observed dynamic changes in labile copper accumulation during brain development 
that was restricted to neuronal processes and the brain ventricles. In contrast, zinc accumulated in the 
neuronal cell bodies, demonstrating that the distribution of these metals is tightly and differentially 
regulated. As predicted, copper deficient calamity mutants, which harbor mutations in the copper 
transporter ATP7A7,  showed a large loss of brain copper levels, especially in neuronal processes. This 
loss was fairly specific to the brain, as total body levels of copper in calamity mutants was similar to wild 
type larvae.  
 
Previous work had demonstrated that NE signaling from the LC in zebrafish larvae is critical for arousal, 
as in mammals5. To investigate whether copper deficiency impacts zebrafish arousal behaviors that are 
mediated through the LC, Xiao et al. examined by videography the impact of copper depletion on larval 
behavioral activity during a 14 hour:10 hour light:dark cycle and on startle responses to an acoustic 
stimulus. They found that both genetic (calamity) and pharmacological (copper chelation) reduction of 
brain copper altered larval behavior in a similar manner to laser-guided ablation of the LC, suggesting 
that copper loss affects behavior via the LC. Consistent with this interpretation, larval LC neurons 
strongly expressed the copper transporters CTR1 and ATP7A, the production of NE is reduced in the LC 
of the copper deficient calamity mutant, and drugs that boost NE signaling can partially rescue calamity 
behavior.  Intriguingly, they also found that the switch to relatively high production of NE over 
dopamine emerged in vertebrate evolution at the time when the ATP7 copper transporter gene family 
expanded.  
What emerges is a model in which copper is loaded into the LC and then shuttled by ATP7A to the DBH 
enzyme for the production of the neurotransmitter NE, which is then involved in modulating behavioral 
arousal (Fig. 1). However, this is only one copper-dependent enzyme/circuit/behavior, and there are 
likely to be many others, as humans with disorders of copper metabolism display a variety of 
neurological phenotypes8. Zebrafish have a wide range of genetically tractable behaviors, from visual-
guided behaviors to social preference, and neuronal activity can be non-invasively monitored 
throughout the brain at single cell resolution9. How the brain and behavior are affected in copper 
deficient mutants should uncover additional copper sensitive circuits.  Finally, how other transition 
metals, such as manganese, impact the zebrafish and human brain have received recent experimental 
attention10. Xiao et al.’s work provides a template for using the fish model to probe the role of metal in 
development, behavior, and disease.  
 
Figure 1. During wakefulness, the locus coeruleus (LC) delivers norepinephrine (NE) across the brain to 
maintain arousal. In the LC, the copper transporters CTR1 and ATP7A load copper onto dopamine-beta 
hydroxylase (DBH), which converts dopamine (DA) into NE. Loss of copper transport impacts NE 
production and reduces arousal.  
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